JPRN-jRCT1032230028招募中Unknown
Direct hemoperfusion with PMMA to adsorb uremic toxins in hemodialysis patients - PMMA-DHP
Yamamoto Suguru0 个研究点目标入组 10 人开始时间: 2023年4月16日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 18age old 至 ot applicable(—)
- 性别
- All
入选标准
- •Patients who meet all the inclusion criteria below,
- •1. Patients who can obtain written informed consent to participate in this study based on their free will.
- •2. Patients who are more than 18 years old.
- •3. Patients undergoing hemodialysis treatment for 4 hours/session and three times a week.
- •4. Patients with dialysis-related amyloidosis have the criteria to use FT-75 and FT-145.
- •5. Patients who do not have residual kidney function.
- •6. Patients with systolic blood pressure at pre-dialysis over 100 mmHg.
- •7. Patients whose blood hemoglobin at pre-dialysis is more than 10.5 g/dL.
排除标准
- •Patients who meet any exclusion criteria are below.
- •1. Patients who participate in other clinical studies.
- •2. Patients who are pregnant or want pregnancy.
- •3. Patients that the investigators decide are inappropriate to join the study.
研究者
相似试验
已完成
不适用
Hemadsorption through supportive establishment of an Oxiris® filter in septic shock with suspected cytokine release syndrome - a randomized controlled intervention studyR57.2Septic shockDRKS00027287Klinik für Anästhesiologie Universitätsklinikum Heidelberg19
进行中(未招募)
不适用
PMMA studyChronic renal failureJPRN-jRCTs032200179Yamamoto Suguru10
进行中(未招募)
1 期
Improving the removal of toxic substances in the blood by two different forms of peritoneal dialysis (a treatment for patients with chronic kidney disease with intraabdominal fluid exchange to remove fluid and toxic substances from the blood whereby the peritoneal membrane serves as a filter).EUCTR2016-004176-22-ATMedizinische Universität Graz22
招募中
不适用
PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTIOBetacoronavirusCOVID-19 infectionCOVID-19Coronavirus InfectionsSARS VirusCoronaviridae InfectionsSevere Acute Respiratory SyndromeRPCEC00000323Institute of Hematology and Immunology Dr. Jose Manuel Ballester Santovenia”
已完成
不适用
Staple-line bleeding reduction using a bioabsorbable reinforcement in day surgery stapled hemorrhoidopexySymptomatic II-III grade haemorrhoids and rectal mucosal prolapseUrological and Genital DiseasesISRCTN33808948a Sapienza University of Rome (Italy)70
